9 months ago

MIPIM Investment Prospectus


ADDLESHAW GODDARD WE ARE A PREMIUM REAL ESTATE PRACTICE BUILT TO MANAGE THE PROPERTY ASSET LIFECYCLE FROM ACQUISITION TO EXIT… We work with clients to deliver iconic developments and transformational projects, and advise on the most complex Real Estate transactions, including international investments and joint ventures, from pre-acquisition, through development, to successful exit. Our award-winning team is one of the largest real estate practices in the market and boasts a truly 360° perspective. Combining innovation with a commitment to client relationships, we are known for delivering what we see as one of the most advanced services in the sector to meet the needs of the globalised real estate market. This is why we remain the trusted advisers to some of the biggest names in global property, including six of the Top 10 UK Asset Managers and 40% of all PropCo's listed in FTSE100. 24

AstraZeneca Turning molecules into medicines for 60 years The North West is an important hub for AstraZeneca – a centre of innovation, science and high-tech manufacturing. It’s a place where creative, talented and committed people can make their mark. It’s a place where molecules are turned into medicines. With more than 4,000 employees, the largest medicines manufacturing facility in the UK and over 800 people who develop new medicines, AstraZeneca is a powerhouse in a region whose people change lives for the better. Macclesfield Our campus at Macclesfield is home to AstraZeneca’s largest Pharmaceutical Technology and Development (PTD) team – it is these people who help transform new discoveries made at our research facilities into medicines that can be manufactured and given to patients. Without Pharmaceutical Development, there’d be new molecules, but no new medicines. These development scientists work closely alongside colleagues who are exceptionally experienced in manufacturing complex medicines. Having these teams working closely together allows AstraZeneca to develop new medicines safely and quickly, ensuring patients can receive innovative new treatments in the fastest time possible. Macclesfield is also home to our second largest IT hub, providing critical systems that support delivery of our life-changing medicines. Alderley Park Seven miles away at Alderley Park, is the site where the first approvals were granted for over 30 medicines discovered in the North West. This site, now owned by Manchester Science Partnerships, sees a fast-growing community of scientific start-up businesses utilising the state of the art laboratory facilities. Many of these exciting new ventures will no doubt spearhead the future of medicines and new scientific discovery. Liverpool In Liverpool we develop and produce flu vaccinations for the UK’s child vaccination programme. The 300 plus team is constantly seeking to improve our ability to beat new strains and mutations to help minimise the impact of the seasonal flu virus. Investing in the future Developing and manufacturing medicines means investing in new plants, equipment and people. At Macclesfield we recently invested £120m into the production of one key anti-cancer drug alone. We are also investing £60m into our state of the art packing and warehouse facility. For AstraZeneca the North West is a vibrant life science cluster, a strong talent pool and a great place to do business. 25